Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DIRECT Therapies

Financiado

Cerrado

Diabetes Immunoengineering Redesigning Encapsulated Cell Transplant Therapies

Diabetes Immunoengineering: Redesigning Encapsulated Cell Transplant Therapies Diabetes remains a global healthcare challenge, affecting 370 million people worldwide. Islet transplantation offers the potential to restore insulin f... ver más

30/06/2021

THE UNIVERSITY OF...

270K€

Presupuesto del proyecto: 270K€

Líder del proyecto

THE UNIVERSITY OF NOTTINGHAM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-06-30

MSCA-IF-2017: Individual Fellowships

I+D

Cerrada hace 7 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

THE UNIVERSITY OF NOTTINGHAM

269.86K€ | Lider

CHILDREN'S HOSPITAL CORPORAT...

CHB

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

EUIN2015-62493 NUEVOS ANDAMIOS 3D PARA TERAPIAS REGENERATIVAS CELULARES. PR... 4K€ Cerrado

ImmunoBioSynth Synergistic engineering of anti tumor immunity by synthetic... 2M€ Cerrado

AngioMatTrain Development of Biomaterial based Delivery Systems for Ischem... 4M€ Cerrado

DPI2011-29216-C02-01 SIMULADOR PARA EL DISEÑO Y DESARROLLO DE ANDAMIOS PARA INGEN... 12K€ Cerrado

DRIVE Diabetes Reversing Implants with enhanced Viability and long... 9M€ Cerrado

VANGUARD New Generation Cell Therapy Bioartificial Pancreas to Cure... 7M€ Cerrado

Duración del proyecto: 38 meses Fecha Inicio: 2018-04-23
Fecha Fin: 2021-06-30

Líder del proyecto

THE UNIVERSITY OF NOTTINGHAM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 270K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Diabetes Immunoengineering: Redesigning Encapsulated Cell Transplant Therapies Diabetes remains a global healthcare challenge, affecting 370 million people worldwide. Islet transplantation offers the potential to restore insulin function in diabetes-1 patients, and is proving successful in human clinical trials. However a major limitation is the requirement for patients to take global immunosuppressive drugs, often daily, for the remainder of their lives. These drugs can impact the quality of life for the patient, and may lead to an impaired immune system at risk of opportunistic pathogens. The scientific aim of this project is to develop innovative multifunctional materials for diabetes-1 cell therapies; those that can better support islet function and also direct the host immune system, removing the need for global immune suppression and enhancing transplant lifetimes. This project connects a talented young researcher with a background in chemistry, biomaterials science and immunoengineering, to a host institution with expertise in drug delivery and tissue engineering (Nottingham), and an internationally renowned outgoing institution (Boston Children's Hospital, Harvard Medical School) with expertise in transplant encapsulation and diabetes therapies. Combining the localised drug delivery expertise of the host institution, the diabetes-1 cell therapy transplant knowledge of the outgoing institution, and the researcher’s own expertise in immunoengineering presents a unique opportunity and new approach to addressing this healthcare challenge, and facilitates development of the researcher's career through a specified training-in-research program. Bridging the gap between the transplant immunology, biomaterials and drug delivery fields in this way meets the Open Innovation, Open Science, Open to the World EU vision towards Open Science and follows the road map for integrative research proposed by the UK Medical Research Councils for regenerative medicine research.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores